On the basis of using the rat adjuvant-induced arthritis model of human RA and microarray technology in this study, we describe the gene expression profiles of arthritic LEW rats at different phases of the disease as well as the modulation of gene expression by a tolerogenic disease-protective regimen employing the disease-related antigen Bhsp65. The gene discussed is PYGL; the disease is Arthritis.